ET receptor antagonist 1 (compound 16h) is an orally active ET receptor antagonist ( IC 50 =0.18 nM), which can be used for research in pulmonary arterial hypertension (PAH). ET receptor antagonist 1 attenuates monocrotaline induced PAH in rat model.